Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Federica Ratti"'
Autor:
Gennaro Ratti, Cinzia Monda, Federica Ratti, Marco Golino, Ludovica Fulgione, Cosimo Fulgione, Mario Mallardo, Paolo Tammaro
Publikováno v:
Monaldi Archives for Chest Disease (2022)
Long term dual antiplatelet therapy (LTDAPT), with ticagrelor 60 mg and low-dose aspirin, is indicated after acute coronary syndrome (ACS) for the secondary prevention of atherothrombotic events in high-risk patients with a history of ACS of at least
Externí odkaz:
https://doaj.org/article/d9b7d8954bc443c193ec160155b22291
Autor:
Gennaro Ratti, Antonio Maglione, Emilia Biglietto, Cinzia Monda, Ciro Elettrico, Federica Ratti, Cosimo Fulgione, Mario Mallardo, Paolo Tammaro
Publikováno v:
Monaldi Archives for Chest Disease (2021)
Long term treatment with ticagrelor 60 mg and low-dose aspirin are indicated after acute coronary syndrome (ACS). We retrospectively reviewed aggregate data of 187 patients (155 M and 38 F) (mean age 63.8±9 years) in follow up after ACS with at leas
Externí odkaz:
https://doaj.org/article/2572885772c143f7bc3c7f30fff64d16
Autor:
Gennaro Ratti, Cristina Di Tommaso, Cinzia Monda, Ciro Elettrico, Federica Ratti, Cosimo Fulgione, Mario Mallardo, Paolo Tammaro
Publikováno v:
European Heart Journal Supplements. 23
Aims Long-term treatment with ticagrelor 60 mg and low-dose aspirin are indicated after acute coronary syndrome (ACS) for the secondary prevention of atherothrombotic events in high-risk patients with a history of myocardial infarction of at least 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3c4b89a228c232e7f3e97aeacc12da33
https://doi.org/10.1093/eurheartj/suab145.007
https://doi.org/10.1093/eurheartj/suab145.007
Autor:
Mario Mallardo, Federica Ratti, Gennaro Ratti, Cosimo Fulgione, Ciro Elettrico, Cinzia Monda, P. Tammaro, Antonio Maglione, Emilia Biglietto
Publikováno v:
Monaldi Archives for Chest Disease (2021)
Long term treatment with ticagrelor 60 mg and low-dose aspirin are indicated after acute coronary syndrome (ACS). We retrospectively reviewed aggregate data of 187 patients (155 M and 38 F) (mean age 63.8±9 years) in follow up after ACS with at leas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c316097d47520a650b9d6787a9dd0e46
https://doi.org/10.4081/monaldi.2021.1881
https://doi.org/10.4081/monaldi.2021.1881